Nasonex

Dermatophytosis, Asthma, Itching + 14 more

Treatment

2 FDA approvals

20 Active Studies for Nasonex

What is Nasonex

Mometasone furoate

The Generic name of this drug

Treatment Summary

Mometasone furoate is a steroid medication used to treat asthma, nasal allergies, and certain skin conditions. It works by blocking the production of certain chemicals in the body, making it very effective in treating inflammation. Mometasone furoate is available in three forms: a dry powder inhaler, nasal spray, and ointment.

Elocon

is the brand name

image of different drug pills on a surface

Nasonex Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Elocon

Mometasone furoate

1987

114

Approved as Treatment by the FDA

Mometasone furoate, also known as Elocon, is approved by the FDA for 2 uses including Asthma and Asthma .

Asthma

Helps manage Asthma

Asthma

Helps manage Asthma

Effectiveness

How Nasonex Affects Patients

Mometasone is a type of corticosteroid that is more powerful than other corticosteroids and is filtered more easily across cell membranes. This helps activate pathways in the body that reduce inflammation.

How Nasonex works in the body

Mometasone is used to treat asthma by preventing cells such as mast cells, eosinophils, basophils, and lymphocytes from releasing chemicals that cause inflammation. It does this by binding to special receptors that are found in the cell's cytosol. When mometasone binds to the receptor, it causes the receptor to change shape and move to the nucleus of the cell. The receptor then binds to a special DNA sequence which boosts the production of anti-inflammatory molecules and stops the production of molecules that cause inflammation. Mometasone also works by blocking certain proteins that drive inflammation.

When to interrupt dosage

The appropriate amount of Nasonex is contingent upon the specified condition, such as Dermatitis, Eczematous induced by superficial Fungal skin infection, Psoriasis and Skin Diseases, Eczematous. The measured quantity of dosage is contingent upon the method of administration (e.g. Powder or Topical) expressed in the following table.

Condition

Dosage

Administration

Dermatophytosis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Asthma

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Itching

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Atopic Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

prophylaxis of seasonal Allergic rhinitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Hay Fever

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Seasonal Allergies

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Skin Diseases, Eczematous

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Systemic Treatment

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Nasal Decongestants

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Communicable Diseases

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Bacterial Infections

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Psoriasis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Dermatitis

, 0.001 mg/mg, 1.0 mg/mL, 0.05 mg, 0.22 mg, 0.11 mg, 0.1 %, 0.2 mg, 0.1 mg, 1.35 mg, 0.01 mg/mg, 1.0 mg, 0.32 mg, 0.08 mg, 0.16 mg, 0.0625 mg, 0.1275 mg, 0.26 mg, 0.136 mg, 0.1 mg/pump actuation, 0.05 mg/spray, 0.2 mg/pump actuation, 0.05 mg/pump actuation, 0.4 mg/pump actuation, 0.025 mg

Ointment - Topical, Topical, , Lotion, Lotion - Topical, Ointment, Spray, metered, Spray, metered - Nasal, Nasal, Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Cream, Cream - Topical, Solution - Topical, Solution, Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol - Respiratory (inhalation), Aerosol, Intrasinal, Implant - Intrasinal, Implant, Powder, Powder - Respiratory (inhalation), Kit, Capsule, Capsule - Respiratory (inhalation), Kit - Topical, Spray, Spray - Nasal

Warnings

Nasonex Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Mometasone Furoate may interact with Pulse Frequency

There are 20 known major drug interactions with Nasonex.

Common Nasonex Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Mometasone furoate.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be increased when combined with Mometasone furoate.

Aldesleukin

Major

The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.

Alectinib

Major

The metabolism of Alectinib can be increased when combined with Mometasone furoate.

Almotriptan

Major

The metabolism of Almotriptan can be decreased when combined with Mometasone furoate.

Nasonex Toxicity & Overdose Risk

Overdosing on a mometasone furoate inhaler can cause symptoms such as increased cortisol levels, and patients may not require further treatment beyond monitoring. In pregnant patients, some fetal side effects have been seen in animal studies at high doses, though humans may be less sensitive. It is unknown if mometasone furoate is passed to babies through breast milk, so caution should be taken when administering to nursing mothers. Clinical trials have shown that mometasone furoate is safe and effective in pediatric populations, although there may be some growth reduction depending on the dose and duration of treatment. Elderly patients may

image of a doctor in a lab doing drug, clinical research

Nasonex Novel Uses: Which Conditions Have a Clinical Trial Featuring Nasonex?

279 clinical trials are being conducted to test the efficacy of Nasonex in providing relief from Atopic Dermatitis, Seasonal Allergies and Psoriasis.

Condition

Clinical Trials

Trial Phases

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Dermatophytosis

0 Actively Recruiting

Systemic Treatment

0 Actively Recruiting

Seasonal Allergies

0 Actively Recruiting

Itching

4 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1

Hay Fever

0 Actively Recruiting

Skin Diseases, Eczematous

0 Actively Recruiting

Bacterial Infections

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

prophylaxis of seasonal Allergic rhinitis

0 Actively Recruiting

Dermatitis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Psoriasis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Nasal Decongestants

8 Actively Recruiting

Early Phase 1, Phase 4, Not Applicable, Phase 3, Phase 2

Atopic Dermatitis

14 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Phase 1

Communicable Diseases

0 Actively Recruiting

Nasonex Reviews: What are patients saying about Nasonex?

5

Patient Review

3/22/2015

Nasonex for Chronic Inflammation of the Nose Not due to Allergies

This medication was an absolute lifesaver. I had sinusitis, chronic infections, and general trouble breathing through my nose before using Nasonex, but this drug really gave me back my life. However, it is criminal how expensive this medication is in the United States.

3.3

Patient Review

5/20/2018

Nasonex for Non-Seasonal Allergic Runny Nose

While it did help with my constant hayfever problem, unfortunately I appear to have most of the unwanted side affects too - total loss of smell and taste, headaches, red eyes, dry mouth/throat, upset tummy, diahrrea, dreadful joint swelling and pain and other symptoms I'm not sure are related to Nasonex or coincidental. Either way, I would much rather a sneezy runny nose 24/7 than these side effects! My life is hell because of this stuff.

2.7

Patient Review

5/12/2015

Nasonex for Inflammation of the Nose due to an Allergy

I've been using this for a few months now and unfortunately haven't seen any benefits. Additionally, it's made in China!

2.7

Patient Review

6/13/2022

Nasonex for Chronic Inflammation of the Nose Not due to Allergies

Though this medicine did help me clear my sinuses, the side effects were really harsh. I felt anxious, had headaches and nausea, and constantly felt like my muscles ached. So unfortunately, I had to stop taking it.

2.3

Patient Review

5/18/2015

Nasonex for Non-Seasonal Allergic Runny Nose

I stopped using this after four days because I woke up on the fifth day with complete blurred vision. I couldn't read any street signs, even though I have perfect vision. This was scary, and I will never use this again.

1.7

Patient Review

3/17/2018

Nasonex for Inflammation of the Nose due to an Allergy

After just three months of using this medication to treat an infected sinus, I started noticing some serious side effects. These included sores in my nose, excessive thirst and fatigue, dry mouth, and a constant sinus headache. All of these problems were caused by the medication, and things only got worse instead of better.

1

Patient Review

5/13/2022

Nasonex for Chronic Inflammation of the Nose Not due to Allergies

Do not use this spray! It made me feel incredibly ill, with muscle pains, headaches, and worse congestion. I was also constantly depressed and crying. This product is absolutely horrible and should be taken off the market.

1

Patient Review

11/27/2014

Nasonex for Allergic Rhinitis Prevention

My A1C levels have been going up since I started this treatment, as well as experiencing changes in my blood pressure and developing a sore throat.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about nasonex

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Nasonex used to treat?

"This medication is used to treat the symptoms of hay fever and perennial rhinitis in adults and children aged 3 years or older."

Answered by AI

How long can you use Nasonex for?

"You can use Nasonex^ Allergy nasal spray for up to six months if needed."

Answered by AI

Does Nasonex clear sinuses?

"The only nose spray currently indicated to treat acute sinusitis is mometasone (Nasonex). Mometasone reduces the number of basophils and eosinophils in the mucous, and inhibits the late-phase reaction after exposure to allergens."

Answered by AI

Is Nasonex a steroid or antihistamine?

"Nasonex is a steroid that is used to treat allergies. It is possible that people with allergies may benefit from taking Nasonex as well as an antihistamine pill or other type of nasal spray."

Answered by AI

Clinical Trials for Nasonex

Image of Waianae Coast Comprehensive Health Center in Waianae, United States.

Community Program for Youth Well-Being

12 - 25
All Sexes
Waianae, HI

The goal of this pilot clinical trial is to learn if a community referral program can improve services for youth with mental health and chronic health conditions in a predominantly Native Hawaiian and Pacific Islander community. The main questions the trial aims to address are: * What is the best way for a community health center to connect youth with community programs rooted in cultural practices and traditions? * Does participation in community programs engage youth and mental health and chronic health outcomes? Participants will: * Participate in a community program for youth that will strengthen connection to 'āina (land) and culture. Programs in the summer are 5 hours per day, 4 days a week, for 4 weeks. Programs in the school-year are 2.5 hours per day, 2 days a week, for 16 weeks. * Take surveys on their demographics, general well-being, mental health, and chronic health conditions they may have at 4 different times: Before the program begins, immediately after the program finishes, 3-4 months after finishing, and 6-8 months after finishing. * Have an adult family member complete surveys on their youth's demographics and general well-being at the same 4 times

Recruiting
Has No Placebo

Waianae Coast Comprehensive Health Center

May M Okihrio, MD, MS

Have you considered Nasonex clinical trials?

We made a collection of clinical trials featuring Nasonex, we think they might fit your search criteria.
Go to Trials
Image of San Francisco VA Medical Center in San Francisco, United States.

Dietary Salt for Eczema

18+
All Sexes
San Francisco, CA

The goal of this clinical trial is to evaluate the feasibility of low-sodium diet to improve eczema severity. The main questions it aims to answer are: * Does a low-sodium diet improve eczema severity? * How does a low-sodium diet impact skin sodium concentration? * Is skin sodium concentration associated with eczema severity? Researchers will ask all participant to follow a low-sodium diet, then compare sodium tablets to a placebo (a look-alike substance that contains no drug) to specifically examine the impact of altering sodium intake. Participants will: * Follow a low-salt diet for the duration of the 24-week study * Take sodium chloride tablets every day for 5 weeks followed by a placebo every day for 5 weeks after a 2-week washout period, or vice versa * Complete up to 4 virtual check-in visits * Visit the clinic 4 times to answer questionnaires, provide bio samples, complete dietary recalls, and undergo non-contrast sodium MRI

Phase 4
Waitlist Available

San Francisco VA Medical Center (+1 Sites)

Katrina Abuabara, MD

Image of Corvus Clinical Trials in South San Francisco, United States.

Soquelitinib for Eczema

18+
All Sexes
South San Francisco, CA

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their AD changes during the study. The study doctors will see how safe soquelitinib is by tracking side effects among participants. They will also check "tolerability," which means how well the participants can handle soquelitinib and whether any potential side effects are manageable for them. To understand how well soquelitinib works, it will be compared with a placebo. Placebo is a substance that looks like soquelitinib but contains no active medicine in it. Participants will: * Take study treatment (soquelitinib or placebo) every day for 12 weeks * Visit the clinic for check-ups and tests every week for the first 2 weeks then every 2 weeks during the treatment period, and then return for follow-up visits 30, 60, and 90 days after the last dose of study treatment

Phase 2
Recruiting

Corvus Clinical Trials

Isin Sinem Bagci, MD

Corvus Pharmaceuticals, Inc.

Have you considered Nasonex clinical trials?

We made a collection of clinical trials featuring Nasonex, we think they might fit your search criteria.
Go to Trials
Image of Seeding Labs INC in Austin, United States.

Tailored Recommendations for Infant Gut Microbiome

No minimum age - 3
All Sexes
Austin, TX

The goal of this clinical trial is to learn whether microbiome analysis, education, and personalized recommendations can improve gut health and reduce early markers of immune-related conditions in infants aged 0-3 months delivered via Cesarean section. The study aims to determine whether these interventions can increase beneficial bacteria, decrease C-section-associated microbiome signatures, reduce opportunistic pathogens, and improve functional potential for HMO digestion and SCFA production. The study also seeks to assess whether improvements in microbiome composition are associated with a reduced prevalence of early atopic symptoms. Researchers will compare three groups: a full intervention arm that receives microbiome reports, coaching, personalized recommendations, and educational materials; a limited intervention arm that receives simplified reports and basic recommendations; and a control arm that receives no results until study completion. This design allows evaluation of both a comprehensive intervention and a more scalable, minimal-results model. Participants will: 1. Provide six microbiome stool samples over a 24-month period. 2. Provide additional small stool samples at two timepoints for exploratory metabolomic analysis. 3. Receive microbiome reports and guidance according to their assigned study arm. 4. Complete surveys on infant health history, symptoms, diet, and environmental exposures. 5. Participate in standardized eczema assessment(s) administered by a Nurse Practitioner and evaluated by a Pediatric Allergy Specialist if any symptoms are reported. This study seeks to demonstrate that targeted microbiome support can positively shift gut microbial development in C-section infants and may reduce risks linked to the early stages of the atopic march. Findings may inform scalable strategies for delivering microbiome-based support in early life and improve long-term health outcomes for this high-risk population.

Recruiting
Has No Placebo

Seeding Labs INC

Qian Yuan, MD

Seeding, Inc DBA Tiny Health

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Verified
Image of Velocity Clinical Research - Medford in Medford, United States.

ENV-294 for Asthma

18 - 75
All Sexes
Medford, OR

This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants will take oral ENV-294 or placebo once daily for 12 weeks. The study includes a screening period of up to 28 days before randomization to confirm eligibility. Study visits and assessments will be conducted to monitor safety, measure drug levels in the blood, and evaluate effects on asthma control and lung function.

Phase 2
Recruiting
Quick Reply

Velocity Clinical Research - Medford (+11 Sites)

Gurpreet Ahluwalia, PhD

Enveda Therapeutics

Have you considered Nasonex clinical trials?

We made a collection of clinical trials featuring Nasonex, we think they might fit your search criteria.
Go to Trials